This review (Biomolecules, Aug 2025; 160 references) surveys continuum solvation from classical electrostatics (PB via DelPhi/APBS, GB variants, AGBNP2, ABSINTH, EEF1) through quantum-continuum models (PCM, COSMO/COSMO-RS, SMx/SMD) and emerging frontiers in ML-augmented and quantum-centric solvation . Its central thesisβthat hybridization (continuum cores + ML correctors + quantum-continuum modules) is the pragmatic path forwardβis well-argued and timely. The most valuable contribution for practitioners is the quantitative ML evidence it compiles: physics-guided neural networks (PGNN) cut host-guest binding error from 8.35 to 2.05 kcal/mol versus GBNSR6, and residual ML corrections reduced GB hydration-free-energy RMSE by ~50% .
Strengths: exceptional breadth (classical β quantum β ML), honest acknowledgment of failures (ion specificity, water bridges, entropy, parameter sensitivity), and fit-for-purpose guidance rather than one-size-fits-all prescriptions . The formulas are traced to primary sources (Still, Onufriev, Klamt, Cramer-Truhlar).
Weaknesses: it creates no new data (explicitly stated), so no independent falsification is offered; some equation transcriptions from GROBID extraction appear garbled (e.g., stylized GB forms); several sections read as summaries of single studies (e.g., GBNSR6, IWM-GB) rather than critical synthesis; and the quantum-computing section rests on a single 2025 preclinical demonstration of SQD/IEF-PCM on small moleculesβits scalability to biomolecules is speculative . Blind spots: no systematic PRISMA-style search, no quantitative comparison table of PB vs GB accuracy across published benchmarks beyond cherry-picked examples, and little discussion of failure statistics on highly charged nucleic acid systems beyond two older studies. What would change the assessment: independent head-to-head benchmarking showing ML correctors fail to transfer beyond their training chemistry (e.g., FreeSolv to host-guest), which would undercut the hybridization thesis.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.